Episode Details

Back to Episodes

Pre-Session Views

Published 4 months ago

Description

In today's views

Strategy | Reiterating small-cap pharma call: Nile Pharma bubble crashed and Memphis Pharma will likely outperform in 2026
MFPC roundtable takeaways | Structural export advantage reinforced, limited CBAM risk, and clear investment path ahead
CICH | 9M25 resilience underscores our EGP13/share fair value
TWSA | Preliminary indicators show promising growth in factoring

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.